A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
about
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionPD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceThe immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product.Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera.Cancer genetics and tumor antigens: time for a combined view?Polymerase chain reaction based human leucocyte antigen genotyping for the investigation of suspected gastrointestinal biopsy contaminationA CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.Tumor antigens discovery: perspectives for cancer therapy.Clinical significance of immune cell infiltration within gallbladder cancer.Cancer immunotherapy targeting neoantigens.Cancer genome sequencing and its implications for personalized cancer vaccines.Specificity in cancer immunotherapy.Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.Benefits of a continuous therapy for cancer patients with a novel adoptive cell therapy by cascade priming (CAPRI).Personalized cancer immunotherapy using Systems Medicine approaches.The future of immunotherapy for sarcoma.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Activated monocytes prime naïve T cells against autologous cancer: vigorous cancer destruction in vitro and in vivo.Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinoma.Cancer immunotherapy by fusions of dendritic and tumour cells and rh-IL-12.Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.Autoimmunity and tumor immunity induced by immune responses to mutations in self.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Allogeneic stem cell transplantation for renal cell carcinoma
P2860
Q22010943-EE3F04DE-3E3A-4956-84F7-84DF6C4C8281Q26865789-23136AA3-BC10-43CB-AC36-3C9E964C7ADEQ30442838-A60BCE8C-7A34-4BA2-955E-80CEC67510F0Q33202641-B61663D8-7F3D-4815-80FB-322228060A03Q33240732-2ED83781-2B68-4B4D-9D0E-0F79F63B7E81Q34495646-3288ADB2-B427-47A7-B084-A0DDEB733BC1Q35356289-A485D725-1AC8-4AE1-BF04-70753F2711A4Q36380492-957CED95-63A2-4F42-9AFD-0AF2B747093EQ36438078-A573B64C-E90B-4203-9956-527226B2A9A3Q36671472-EF8C2BC5-737C-4EFB-8470-006EC1DBA04DQ36889067-733D6303-9966-4833-B618-80C216DDB60FQ37148184-5D3E8A65-8B95-4DD2-835D-52CA4F44E030Q37236636-A3001CAC-45C1-4490-B881-D63FF8732982Q37330688-D8CDACD0-55FD-4C28-B888-E0599554F777Q38206816-2175FAAE-38CA-49BB-AB6E-AC71C7DCB924Q38547040-80399C52-C1B3-40FD-B6EC-06D10844BFB9Q38829558-B1148278-246B-49EF-B898-EF69B9C226A8Q39057617-4BA682EF-1E42-43AC-85FD-AA2A7EE645C7Q39458843-A0FBE8A3-5A8F-40DB-ABD4-40E8C8841D9BQ40464159-C86F78EA-5DBD-4687-8DEA-6E3EAE911B38Q40511274-71D41CA3-267C-4F60-B652-79778BA5E367Q43557973-AC3D2961-9F8C-4EBC-8CF4-AE0E267ABFDCQ45284671-B86C6A59-D8EE-4D09-B1C5-22B90F25FCD4Q46917393-7784FE66-3B57-4120-ADD0-DBC37F19CE29Q49432766-836C967F-65F1-4745-806F-D8FDA6CBB948Q58049115-EEE069D1-36B6-4915-B6B1-27F015588A04
P2860
A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@ast
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@en
type
label
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@ast
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@en
prefLabel
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@ast
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@en
P2093
P2860
P356
P1476
A mutated HLA-A2 molecule reco ...... a human renal cell carcinoma.
@en
P2093
Brasseur F
Van den Eynde B
Weynants P
P2860
P304
P356
10.1084/JEM.183.6.2501
P407
P577
1996-06-01T00:00:00Z